Champions Oncology Inc (NASDAQ:CSBR) price on current trading day, rose 20.39% above its previous day’s close as an upside momentum from buyers pushed the stock’s value to $4.90.
A look at the stock’s price movement, the level at last check in today’s session was $4.07, moving within a range at $4.7 and $5.23. Turning to its 52-week performance, $7.13 and $3.60 were the 52-week high and 52-week low respectively. Overall, CSBR moved 5.87% over the past month.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Champions Oncology Inc’s market cap currently stands at around $66.59 million, with investors looking forward to this quarter’s earnings report slated for on 2024-Dec-10.
Analysts have a consensus estimate of 13.32M for the company’s revenue for the quarter, with a low and high estimate of 13.32M and 13.32M respectively. Wall Street analysts have also projected the company’s year-on-year revenue to grow to 53.67M, representing a 7.00% jump on that reported in the last financial year.
Turning to the stock’s technical picture we see that short term indicators suggest on average that CSBR is a 50% Sell. On the other hand, the stock is on average a 50% Sell as suggested by medium term indicators while long term indicators are putting the stock in 50% Sell category.
CSBR’s current price about 12.08% and 4.41% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 60.08, while 7-day volatility ratio is 11.12% and 6.16% in the 30-day chart. Further, Champions Oncology Inc (CSBR) has a beta value of 0.46, and an average true range (ATR) of 0.38.
If we refocus on Champions Oncology Inc (NASDAQ:CSBR), historical trading data shows that trading volumes averaged 22730.0 over the past 10 days and 7.06K over the past 3 months. The company’s latest data on shares outstanding shows there are 13.56 million shares.
The 55.98% of Champions Oncology Inc’s shares are in the hands of company insiders while institutional holders own 20.10% of the company’s shares. Also important is the data on short interest which shows that short shares stood at 48428.0 on 2024-08-15, giving us a short ratio of 12.51. The data shows that as of 2024-08-15 short interest in Champions Oncology Inc (CSBR) stood at 69.99999799999999 of shares outstanding, with shares short falling to 49125.0 registered in 2024-07-15. Current price change has pushed the stock -12.81% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the CSBR stock continues to rise going into the next quarter.
